Comparative Study of Gemcitabine Versus Cisplatin Concurrent with Radiotherapy for Locally Advanced Head and Neck Cancer

@inproceedings{Ali2014ComparativeSO,
  title={Comparative Study of Gemcitabine Versus Cisplatin Concurrent with Radiotherapy for Locally Advanced Head and Neck Cancer},
  author={Elsayed Mostafa Ali and Emad Eldin Nabil and Ashraf Elyamany and Ahmed Marzouk Maklad and Ahmed Gaber Abdelraheem},
  year={2014}
}
PURPOSE: In our study we compared low-dose gemcitabine-based chemoradiotherapy with cisplatin-based chemoradiotherapy as regards response rate, survival and toxicity profile in locally advanced head and neck cancer. Methodology: sixty patients with locally advanced head and neck cancer were included in this prospective comparative randomized study, in the period from January 2011 to September 2013. Results: The patients were treated in two randomized groups; each of them included 30 patients… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Department of Clinical Oncology, King Edward Medical College / Mayo Hospital, Lahore

Shaharyar, Abrar Ahmed Javed, Ijaz Hussain Shah
  • Pak J Med Sci July - September
  • 2006
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2004
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

May 20 suppl; abstr 17032)

R Sharma, D Abrol, S Kaur
  • J Clin Oncol
  • 2008
VIEW 1 EXCERPT

Phase II trial of Radiotherapy Concurrent with Low Dose Gemcitabine for Management of Locally Advanced Non-resectable Head and Neck Cancer; Faculty of Medicine Minia

Mohamed Abd El-Aziz Sonosy
  • 2007
VIEW 2 EXCERPTS

Phase II trial of Radiotherapy Concurrent with Low Dose Gemcitabine for Management of Locally Advanced Nonresectable Head and Neck Cancer

Mohamed Abd El-Aziz Sonosy
  • Afr Health Sci
  • 2007